Vanguard Portfolio Management
KALV

Vanguard Portfolio Management’s KalVista Pharmaceuticals KALV Stock Holding History

Vanguard Portfolio Management’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-362,900
Closed -$7.31M – 3199
2026
Q1 		$7.31M Buy
+362,900
New +$5.85M ﹤0.01% 2215

Other funds holding KALV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Portfolio Management's KALV Position: Q2 2026 in Review

Vanguard Portfolio Management sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 362,900 shares — an estimated $7.31M sold.

Vanguard Portfolio Management first reported a position in KALV in Q1 2026 and held it in 1 quarter. The position peaked at $7.31M in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

  • Vanguard Portfolio Management reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Vanguard Portfolio Management sold 362,900 KalVista Pharmaceuticals shares in Q2 2026, an estimated $7.31M.
  • Vanguard Portfolio Management first reported a position in KalVista Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Vanguard Portfolio Management's KalVista Pharmaceuticals position peaked at $7.31M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.